☰

Bethany N. Hannafon, Ph.D. - Publications

Affiliations: 
2010 Boston University, Boston, MA, United States 
Area:
Molecular Biology, Genetics
Tree Info Grants Similar researchers PubMed Report error

32 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Dogra S, Elayapillai SP, Qu D, Pitts K, Filatenkov A, Houchen CW, Berry WL, Moxley K, Hannafon BN. Targeting doublecortin-like kinase 1 reveals a novel strategy to circumvent chemoresistance and metastasis in ovarian cancer. Cancer Letters. 216437. PMID 37838282 DOI: 10.1016/j.canlet.2023.216437  0.315
2022 Burrows K, Figueroa-Hall LK, Alarbi AM, Stewart JL, Kuplicki R, Tan C, Hannafon BN, Ramesh R, Savitz J, Khalsa S, Teague TK, Risbrough VB, Paulus MP. Association between inflammation, reward processing, and ibuprofen-induced increases of miR-23b in astrocyte-enriched extracellular vesicles: A randomized, placebo-controlled, double-blind, exploratory trial in healthy individuals. Brain, Behavior, & Immunity - Health. 27: 100582. PMID 36605933 DOI: 10.1016/j.bbih.2022.100582  0.301
2021 Xu YF, Xu X, Bhandari K, Gin A, Rao CV, Morris KT, Hannafon BN, Ding WQ. Isolation of extra-cellular vesicles in the context of pancreatic adenocarcinomas: Addition of one stringent filtration step improves recovery of specific microRNAs. Plos One. 16: e0259563. PMID 34784377 DOI: 10.1371/journal.pone.0259563  0.373
2021 Hannafon BN. Involvement of the Tumor Microenvironment in the Pathogenesis of Breast Cancer. The American Journal of Pathology. PMID 34097898 DOI: 10.1016/j.ajpath.2021.05.012  0.324
2021 Dogra S, Hannafon BN. Breast Cancer Microenvironment Cross Talk through Extracellular Vesicle RNAs. The American Journal of Pathology. PMID 33895121 DOI: 10.1016/j.ajpath.2021.03.014  0.32
2020 Xu YF, Xu X, Gin A, Nshimiyimana JD, Mooers BHM, Caputi M, Hannafon BN, Ding WQ. SRSF1 regulates exosome microRNA enrichment in human cancer cells. Cell Communication and Signaling : Ccs. 18: 130. PMID 32819370 DOI: 10.1186/S12964-020-00615-9  0.545
2019 Hannafon BN, Cai A, Calloway CL, Xu YF, Zhang R, Fung KM, Ding WQ. miR-23b and miR-27b are oncogenic microRNAs in breast cancer: evidence from a CRISPR/Cas9 deletion study. Bmc Cancer. 19: 642. PMID 31253120 DOI: 10.1186/S12885-019-5839-2  0.536
2019 Xu YF, Hannafon BN, Khatri U, Gin A, Ding WQ. The Origin of Exosomal miR-1246 in Human Cancer Cells. Rna Biology. PMID 30806147 DOI: 10.1080/15476286.2019.1585738  0.455
2019 Hannafon BN, Gin AL, Xu YF, Bruns M, Calloway CL, Ding WQ. Metastasis-associated protein 1 (MTA1) is transferred by exosomes and contributes to the regulation of hypoxia and estrogen signaling in breast cancer cells. Cell Communication and Signaling : Ccs. 17: 13. PMID 30782165 DOI: 10.1186/S12964-019-0325-7  0.509
2018 Jiao Y, Watts T, Xue J, Hannafon B, Ding WQ. Sorafenib and docosahexaenoic acid act in synergy to suppress cancer cell viability: a role of heme oxygenase 1. Bmc Cancer. 18: 1042. PMID 30367621 DOI: 10.1186/S12885-018-4946-9  0.405
2018 Hannafon BN, Ding WQ. Functional Role of microRNAs in the Progression of Breast Ductal Carcinoma in situ. The American Journal of Pathology. PMID 30273605 DOI: 10.1016/J.Ajpath.2018.06.025  0.523
2017 Hannafon BN, Ding WQ. microRNAs as Biomarkers for Predicting the Progression of Ductal Carcinoma in Situ. The American Journal of Pathology. PMID 29246496 DOI: 10.1016/J.Ajpath.2017.11.003  0.406
2017 Xu YF, Hannafon BN, Zhao YD, Postier RG, Ding WQ. Plasma exosome miR-196a and miR-1246 are potential indicators of localized pancreatic cancer. Oncotarget. 8: 77028-77040. PMID 29100367 DOI: 10.18632/Oncotarget.20332  0.485
2017 Xu YF, Hannafon BN, Ding WQ. microRNA regulation of human pancreatic cancer stem cells. Stem Cell Investigation. 4: 5. PMID 28217707 DOI: 10.21037/Sci.2017.01.01  0.549
2017 Jiao Y, Hannafon BN, Zhang RR, Fung KM, Ding WQ. Docosahexaenoic acid and disulfiram act in concert to kill cancer cells: a mutual enhancement of their anticancer actions. Oncotarget. PMID 28107189 DOI: 10.18632/Oncotarget.14702  0.461
2016 Hannafon BN, Trigoso YD, Calloway CL, Zhao YD, Lum DH, Welm AL, Zhao ZJ, Blick KE, Dooley WC, Ding WQ. Plasma exosome microRNAs are indicative of breast cancer. Breast Cancer Research : Bcr. 18: 90. PMID 27608715 DOI: 10.1186/S13058-016-0753-X  0.52
2016 Jiao Y, Hannafon BN, Ding WQ. Disulfiram's anticancer activity: evidences and mechanisms. Anti-Cancer Agents in Medicinal Chemistry. PMID 27141876 DOI: 10.2174/1871520615666160504095040  0.3
2016 Hannafon BN, Trigoso YD, Lum DH, Welm AL, Dooley WC, Ding W. Abstract A55: Exosome-associated microRNAs as plasma biomarkers for breast cancer Molecular Cancer Research. 14. DOI: 10.1158/1557-3125.Advbc15-A55  0.487
2015 Hannafon BN, Ding WQ. Cancer stem cells and exosome signaling. Stem Cell Investigation. 2: 11. PMID 27358879 DOI: 10.3978/J.Issn.2306-9759.2015.05.02  0.406
2015 Hannafon BN, Carpenter KJ, Berry WL, Janknecht R, Dooley WC, Ding WQ. Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA). Molecular Cancer. 14: 133. PMID 26178901 DOI: 10.1186/S12943-015-0400-7  0.478
2015 Wang S, Hannafon BN, Lind SE, Ding WQ. Zinc Protoporphyrin Suppresses β-Catenin Protein Expression in Human Cancer Cells: The Potential Involvement of Lysosome-Mediated Degradation. Plos One. 10: e0127413. PMID 26000787 DOI: 10.1371/Journal.Pone.0127413  0.376
2015 Zhang S, Xue J, Zheng J, Wang S, Zhou J, Jiao Y, Geng Y, Wu J, Hannafon BN, Ding WQ. The superoxide dismutase 1 3'UTR maintains high expression of the SOD1 gene in cancer cells: The involvement of the RNA-binding protein AUF-1. Free Radical Biology & Medicine. 85: 33-44. PMID 25908445 DOI: 10.1016/J.Freeradbiomed.2015.04.012  0.446
2015 Hannafon BN, Carpenter K, Berry W, Janknecht R, Dooley W, Ding W. Abstract 5205: Docosahexaenoic acid (DHA) alters breast cancer exosome-mediated microRNA signaling Cancer Research. 75: 5205-5205. DOI: 10.1158/1538-7445.Am2015-5205  0.577
2014 Xue J, Moyer A, Peng B, Wu J, Hannafon BN, Ding WQ. Chloroquine is a zinc ionophore. Plos One. 9: e109180. PMID 25271834 DOI: 10.1371/Journal.Pone.0109180  0.327
2014 Wang S, Hannafon BN, Wolf RF, Zhou J, Avery JE, Wu J, Lind SE, Ding WQ. Characterization of docosahexaenoic acid (DHA)-induced heme oxygenase-1 (HO-1) expression in human cancer cells: the importance of enhanced BTB and CNC homology 1 (Bach1) degradation. The Journal of Nutritional Biochemistry. 25: 515-25. PMID 24613086 DOI: 10.1016/J.Jnutbio.2013.12.011  0.402
2013 Wang S, Hannafon BN, Zhou J, Ding WQ. Clofibrate induces heme oxygenase 1 expression through a PPARα-independent mechanism in human cancer cells. Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology. 32: 1255-64. PMID 24247298 DOI: 10.1159/000354524  0.464
2013 Xue J, Wang S, Wu J, Hannafon BN, Ding WQ. Zinc at sub-cytotoxic concentrations induces heme oxygenase-1 expression in human cancer cells. Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology. 32: 100-10. PMID 23868099 DOI: 10.1159/000350128  0.458
2013 Hannafon BN, Ding WQ. Intercellular communication by exosome-derived microRNAs in cancer. International Journal of Molecular Sciences. 14: 14240-69. PMID 23839094 DOI: 10.3390/Ijms140714240  0.516
2013 Wang S, Avery JE, Hannafon BN, Lind SE, Ding WQ. Zinc protoporphyrin suppresses cancer cell viability through a heme oxygenase-1-independent mechanism: the involvement of the Wnt/β-catenin signaling pathway. Biochemical Pharmacology. 85: 1611-8. PMID 23523860 DOI: 10.1016/J.Bcp.2013.03.011  0.442
2011 Hannafon BN, Sebastiani P, de las Morenas A, Lu J, Rosenberg CL. Expression of microRNA and their gene targets are dysregulated in preinvasive breast cancer. Breast Cancer Research : Bcr. 13: R24. PMID 21375733 DOI: 10.1186/Bcr2839  0.58
2007 Liu T, Hannafon B, Gill L, Kelly W, Benbrook D. Flex-Hets differentially induce apoptosis in cancer over normal cells by directly targeting mitochondria. Molecular Cancer Therapeutics. 6: 1814-22. PMID 17575110 DOI: 10.1158/1535-7163.Mct-06-0279  0.36
2005 Benbrook DM, Kamelle SA, Guruswamy SB, Lightfoot SA, Rutledge TL, Gould NS, Hannafon BN, Dunn ST, Berlin KD. Flexible heteroarotinoids (Flex-Hets) exhibit improved therapeutic ratios as anti-cancer agents over retinoic acid receptor agonists. Investigational New Drugs. 23: 417-28. PMID 16133793 DOI: 10.1007/S10637-005-2901-5  0.408
Show low-probability matches.